FDA Inspection 1074872 — California Pharmacy & Compounding Center

California Pharmacy & Compounding Center — FEI 3004600090

The FDA completed an inspection of California Pharmacy & Compounding Center on December 17, 2018 in Newport Beach, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 17, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newport Beach, CA (United States)

Citations

IDCFRDescription
18938FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination